Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy

Carmel Medical Center40 enrolled

Overview

In our prospective, randomized, placebo controlled and double-blinded study we will study the efficacy of intraperitoneal ropivacaine nebulization on pain relief during gynecological laparoscopic surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

Conditions

Laparoscopic Surgical Procedures

Interventions

ropivacaineDRUG

1% ropivacaine

Aeroneb Pro Nezulizer, Aerogen, IrelandDEVICE

Aeroneb Pro Nezulizer, Aerogen, Ireland

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Elective gynecologic laparoscopic surgery including unilateral or bilateral salpingo-oopherectomy or ovarian cystectomy. * The patient is not participating in other medical study at present or in the last 30 days. * The patient signed on an informed consent. * Age 18 years and above. * ASA (American Society of Anesthesiologists) physical status grade 1- 2. Exclusion Criteria: * Allergy to Ropivacaine, other local anesthetics or other medications listed in the protocol. * The patient is participating in other medical experiment at present or in the last 30 days. * Acute Pelvic Inflammatory Disease. * Coumadin or Aspirin treatment. * ASA physical status grade 3-4. * Age \< 18 years. * Significant arrythmias * Analgesic treatment for chronic pain

Locations (1)

the Carmel Medical Center Ambulatory Gynecoendoscopic Unit

Haifa, Israel

Outcomes

Primary Outcomes

VAS score

Time frame: early post-operative

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.